DHR:NYE-Danaher Corporation (USD)

COMMON STOCK | Diagnostics & Research |

Last Closing

USD 270.03

Change

-0.49 (-0.18)%

Market Cap

USD 197.82B

Volume

1.13M

Analyst Target

USD 220.40
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company has a research collaboration with Stanford University's Department of Bioengineering for cancer drug development. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-04 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
IQV IQVIA Holdings Inc

+2.44 (+1.07%)

USD 42.80B
A Agilent Technologies Inc

+0.42 (+0.29%)

USD 41.65B
LH Laboratory Corporation of Amer..

+0.93 (+0.43%)

USD 18.06B
DGX Quest Diagnostics Incorporated

-1.34 (-0.88%)

USD 17.19B
QGEN Qiagen NV

+0.03 (+0.07%)

USD 10.05B
CRL Charles River Laboratories

+1.15 (+0.61%)

USD 9.79B
VNRX Volitionrx Ltd

+0.12 (+16.21%)

USD 0.06B
ENZ Enzo Biochem Inc

+0.01 (+0.88%)

USD 0.06B
TMO Thermo Fisher Scientific Inc

-2.31 (-0.38%)

N/A
MTD Mettler-Toledo International I..

-10.58 (-0.72%)

N/A

ETFs Containing DHR

SYNB Putnam Biorevolution ETF 7.44 % 0.00 %

+0.20 (+1.49%)

USD 5.43M
AILG 6.99 % 0.00 %

N/A

N/A
LIFE-U:CA Evolve Global Healthcare .. 5.53 % 0.00 %

N/A

N/A
LIFE:CA Evolve Global Healthcare .. 5.09 % 0.69 %

+0.05 (+1.49%)

CAD 0.21B
ZWHC:CA BMO Covered Call Health C.. 4.69 % 0.00 %

-0.04 (1.49%)

N/A
BCHP 4.40 % 0.00 %

N/A

N/A
XGEN:XETRA Xtrackers MSCI Genomic He.. 4.34 % 0.00 %

+0.11 (+1.49%)

N/A
WHCS:SW iShares MSCI World Health.. 4.21 % 0.00 %

N/A

N/A
XDG3:XETRA Xtrackers MSCI Global SDG.. 4.18 % 0.00 %

-0.08 (1.49%)

USD 0.15B
YALL God Bless America ETF 4.17 % 0.00 %

+0.47 (+1.49%)

N/A
XGES:LSE Xtrackers MSCI Genomic He.. 4.11 % 0.00 %

N/A

N/A
CBUF:F iShares V Public Limited .. 4.06 % 0.00 %

-0.01 (1.49%)

N/A
SANE 3.95 % 0.00 %

N/A

N/A
MIVG:CA Mackenzie Ivy Global Equi.. 3.92 % 0.89 %

N/A

CAD 0.02B
NUSA:CA NBI Active U.S. Equity ET.. 3.84 % 0.00 %

+0.28 (+1.49%)

CAD 0.05B
GDOC Goldman Sachs ETF Trust 3.75 % 0.00 %

+0.03 (+1.49%)

USD 0.02B
XLV Health Care Select Sector.. 3.17 % 0.13 %

+0.12 (+1.49%)

USD 41.71B
XUHC:SW Xtrackers MSCI USA Health.. 3.16 % 0.00 %

N/A

USD 0.68B
IUHC:SW iShares S&P 500 Health Ca.. 3.06 % 0.00 %

-0.07 (1.49%)

N/A
GXLV:LSE SPDR® S&P® U.S. Health .. 3.06 % 0.00 %

-0.15 (1.49%)

N/A
SXLV:SW SPDR S&P U.S. Health Care.. 3.06 % 0.00 %

-0.40 (1.49%)

N/A
CNEQ The Alger ETF Trust 2.83 % 0.00 %

+0.34 (+1.49%)

N/A
HIUS:PA HSBC MSCI USA Islamic ESG.. 2.78 % 0.00 %

+0.24 (+1.49%)

N/A
HIUA:SW HSBC MSCI USA Islamic ESG.. 2.78 % 0.00 %

N/A

USD 0.03B
INNO Harbor Disruptive Innovat.. 2.76 % 0.00 %

+0.26 (+1.49%)

N/A
WEBD:XETRA AETF-MUSCNZAP EOA ETF 2.72 % 0.00 %

+0.18 (+1.49%)

N/A
USRI:LSE 2.50 % 0.00 %

N/A

N/A
DSAE:CA Desjardins Sustainable Am.. 2.34 % 0.00 %

N/A

CAD 1.23M
UPVLE:SW UBS (Irl) ETF plc - Facto.. 2.31 % 0.00 %

N/A

USD 0.02B
UPVLD:SW UBS (Irl) ETF plc - Facto.. 2.31 % 0.00 %

+0.22 (+1.49%)

USD 0.18B
UPVLH:SW UBS (Irl) ETF plc - Facto.. 2.31 % 0.00 %

N/A

USD 8.40M
ASRP:XETRA BNP Paribas Easy ECPI Glo.. 2.30 % 0.00 %

+0.01 (+1.49%)

N/A
CURE Direxion Daily Healthcare.. 2.21 % 1.06 %

+0.21 (+1.49%)

USD 0.18B
MEDTE:PA BNP Paribas Easy ECPI Glo.. 2.20 % 0.00 %

+0.02 (+1.49%)

N/A
MTUSD:PA BNP Paribas Easy ECPI Glo.. 2.20 % 0.00 %

-0.11 (1.49%)

N/A
TDOC:CA TD Global Healthcare Lead.. 2.05 % 0.00 %

+0.01 (+1.49%)

CAD 0.09B
HYLG Global X Funds - Global X.. 1.44 % 0.00 %

+0.03 (+1.49%)

N/A
LESW:LSE 1.38 % 0.00 %

N/A

N/A
WSRI:LSE 1.30 % 0.00 %

N/A

N/A
WELB:XETRA Amundi MSCI ACWI SRI PAB .. 1.08 % 0.00 %

-0.02 (1.49%)

N/A
RAVI FlexShares Ready Access V.. 0.86 % 0.25 %

-0.04 (1.49%)

USD 1.09B
CWW.A:CA 0.00 % 1.49 %

N/A

N/A
FHLC Fidelity® MSCI Health Ca.. 0.00 % 0.08 %

+0.15 (+1.49%)

USD 2.97B
IXJ iShares Global Healthcare.. 0.00 % 0.46 %

+0.02 (+1.49%)

N/A
IYH iShares U.S. Healthcare E.. 0.00 % 0.43 %

+0.11 (+1.49%)

N/A
JHMH 0.00 % 0.46 %

N/A

N/A
JMIN 0.00 % 0.12 %

N/A

N/A
EVSTC 0.00 % 0.00 %

N/A

N/A
HIG:CA Global Healthcare Income .. 0.00 % 1.02 %

+0.02 (+1.49%)

CAD 0.05B
LS:CA 0.00 % 2.21 %

N/A

N/A
HWF:CA 0.00 % 0.00 %

N/A

N/A
HTEC Robo Global® Healthcare .. 0.00 % 0.00 %

+0.36 (+1.49%)

USD 0.06B
RXL ProShares Ultra Health Ca.. 0.00 % 0.95 %

+0.20 (+1.49%)

N/A
VHT Vanguard Health Care Inde.. 0.00 % 0.10 %

+0.47 (+1.49%)

N/A
IHCU:LSE iShares S&P 500 Health Ca.. 0.00 % 0.00 %

-4.38 (1.49%)

N/A
IUHC:LSE iShares S&P 500 USD Healt.. 0.00 % 0.00 %

-0.07 (1.49%)

USD 2.54B
SXLV:LSE SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

-0.23 (1.49%)

N/A
UC96:LSE UBS (Irl) ETF plc - Facto.. 0.00 % 0.00 %

+2.00 (+1.49%)

USD 0.18B
UPVL:LSE UBS (Irl) ETF plc - Facto.. 0.00 % 0.00 %

+0.50 (+1.49%)

USD 8.44M
XDWH:LSE Xtrackers MSCI World Heal.. 0.00 % 0.00 %

-0.35 (1.49%)

N/A
XSHC:LSE Xtrackers MSCI USA Health.. 0.00 % 0.00 %

-21.25 (1.49%)

USD 0.67B
XUHC:LSE Xtrackers MSCI USA Health.. 0.00 % 0.00 %

-0.33 (1.49%)

USD 0.67B
EMWE:PA BNP Paribas Easy MSCI Wor.. 0.00 % 0.00 %

+0.05 (+1.49%)

USD 0.78B
EWRD:PA BNP Paribas Easy MSCI Wor.. 0.00 % 0.00 %

+0.01 (+1.49%)

USD 0.09B
USRI:PA AMUNDI MSCI USA SRI Clima.. 0.00 % 0.00 %

+0.18 (+1.49%)

USD 1.94B
EMWE:F BNP Paribas Easy - MSCI W.. 0.00 % 0.00 %

+0.07 (+1.49%)

N/A
GNAR:F 0.00 % 0.00 %

N/A

N/A
QDVG:F iShares S&P 500 Health Ca.. 0.00 % 0.00 %

+0.07 (+1.49%)

N/A
UBUS:F UBS (Irl) ETF Public Limi.. 0.00 % 0.00 %

+0.28 (+1.49%)

USD 0.18B
UBUW:F UBS (Irl) ETF Public Limi.. 0.00 % 0.00 %

+0.13 (+1.49%)

USD 0.02B
XAMB:F Amundi Index Solutions - .. 0.00 % 0.00 %

+1.08 (+1.49%)

N/A
XUHC:F Xtrackers (IE) Public Lim.. 0.00 % 0.00 %

+0.22 (+1.49%)

USD 0.85B
ZPDH:F SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

+0.23 (+1.49%)

USD 0.40B
DXSF:XETRA Xtrackers - Stoxx Europe .. 0.00 % 0.00 %

+0.50 (+1.49%)

USD 0.08B
EMWE:XETRA BNP Paribas Easy MSCI Wor.. 0.00 % 0.00 %

+0.13 (+1.49%)

USD 0.55B
EWRD:XETRA 0.00 % 0.00 %

N/A

N/A
GNAR:XETRA 0.00 % 0.00 %

N/A

N/A
QDVG:XETRA iShares S&P 500 Health Ca.. 0.00 % 0.00 %

-0.01 (1.49%)

USD 2.05B
UBUS:XETRA UBS (Irl) ETF plc - Facto.. 0.00 % 0.00 %

+0.15 (+1.49%)

USD 0.49B
UBUW:XETRA UBS (Irl) ETF plc - Facto.. 0.00 % 0.00 %

+0.01 (+1.49%)

USD 0.05B
VMOM:XETRA 0.00 % 0.00 %

N/A

N/A
XUHC:XETRA Xtrackers MSCI USA Health.. 0.00 % 0.00 %

-0.02 (1.49%)

USD 0.85B
ZPDH:XETRA SPDR S&P U.S. Health Care.. 0.00 % 0.00 %

-0.04 (1.49%)

USD 0.40B
XOUT GraniteShares XOUT U.S. L.. 0.00 % 0.00 %

N/A

N/A
PFUT Putnam Sustainable Future.. 0.00 % 0.00 %

+0.21 (+1.49%)

USD 0.30B

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.72% 85% B 73% C
Dividend Return 0.35% 43% F 4% F
Total Return 17.07% 85% B 68% D+
Trailing 12 Months  
Capital Gain 24.31% 77% C+ 62% D
Dividend Return 0.61% 43% F 6% D-
Total Return 24.91% 77% C+ 55% F
Trailing 5 Years  
Capital Gain 90.63% 75% C 82% B
Dividend Return 3.24% 40% F 9% A-
Total Return 93.87% 75% C 80% B-
Average Annual (5 Year Horizon)  
Capital Gain 13.18% N/A N/A 75% C
Dividend Return 13.57% N/A N/A 71% C-
Total Return 0.39% N/A N/A 10% F
Risk Return Profile  
Volatility (Standard Deviation) 29.22% N/A N/A 35% F
Risk Adjusted Return 46.44% N/A N/A 63% D
Market Capitalization 197.82B 100% F 99% N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor return on assets

The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.